Mubadala, Novo Holdings acquire EUR 250m shares in Evotec SE

CountryUnited Arab Emirates

UAE - Mubasher: Mubadala Investment Company and Novo Holdings will acquire 11.48 million shares in Germany-headquartered Evotec SE with a total value of EUR 250 million, as part of Evotec's plan to raise its capital. The UAE's Mubadala will invest EUR 200 million to own around 5.6% of the outstanding shares of Evotec, a drug discovery and development company, according to a press release on Tuesday. Meanwhile, Evotec’s existing shareholder Novo Holdings will increase its ownership in the company to nearly 11% of outstanding shares in exchange for EUR 50 million. Evotec’s shares will be issued at a price of EUR 21.78 per share. After recording the capital increase in the commercial register, Evotec’s more...